CRL

#969
Charles River Laboratories International, Inc.
183.4650 USD
+2.35%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
180.6800
183.9800
年范围
146.4900
228.8800
日变化
+2.35%
每月变动
+16.53%
6个月变化
-6.80%
年变化
-6.80%
前一天收盘价
179.2500
开盘价
180.7400
买价
卖价
最低价
180.6800
High
183.9800
交易量
94
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 9.0316 B
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-69.81
市销率
2.51

Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

新闻